(MedPage Today) — Adding an investigational drug called clofutriben to corticosteroid therapy could make the latter less toxic in long-term use, a pilot trial in patients with polymyalgia rheumatica (PMR) suggested.
When clofutriben was added…
Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/118497
Author :
Publish date : 2025-11-13 15:13:00
Copyright for syndicated content belongs to the linked Source.
